Investegate |Clinical Ink Announcements | Clinical Ink: Clinical ink Selected for Global Late Phase Parkinson's Disease Programs
Investegate announcements from Clinical Ink, Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
Stay updated with breaking news from Direct Data Capture. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Clinical Ink, Clinical ink Selected for Global Late Phase Parkinson’s Disease Programs
Combining eCOA and Ground-Breaking Movement Disorders Digital Biomarker Platform to Evaluate and Predict PD Severity....
Investegate announcements from Clinical Ink, Clinical ink Again Ranked Among Fastest-Growing Companies in North America on the 2022 Deloitte Technology Fast 500™
Attributes 241% revenue growth to technological innovation and therapeutic expertiseHorsham, Pennsylvania, USA, Nov. 16, 2022, a global life science technology company, today announced its second consecutive
A research study within the US Military Health System deploys Clinical ink’s self-testing mobile platform among those with and without COVID-19 to...